EU drug agency starts evaluating new COVID-19 treatment
- Xevudy is a so-called monoclonal antibody treatment, a laboratory-made version of virus-blocking antibodies that help fight off infections
- European Medicines Agency said it has begun evaluating an application for marketing authorization
